LifeMD, Inc. — Director's Dealing 2017

Nov 21, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: DiTrolio Joseph (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	72500	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$0.2	2022-09-12	Common Stock, par value $0.01 (100000)		Direct
Option	$0.2	2024-09-04	Common Stock, par value $0.01 (250000)		Direct
Option	$0.4	2024-09-04	Common Stock, par value $0.01 (125000)		Direct
Option	$0.35	2027-07-01	Common Stock, par value $0.01 (100000)		Direct